Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
OPT
Stock Latest News
The Fly
Opthea terminates COAST trial, announces ShORe trial misses endpoint
1d ago
OPT
Premium
The Fly
Opthea downgraded to Perform from Outperform at Oppenheimer
7d ago
OPT
Premium
The Fly
Opthea downgraded to Market Perform from Outperform at Leerink
7d ago
OPT
Premium
The Fly
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
7d ago
OPT
Premium
The Fly
Opthea double downgraded to Underperform from Buy at Jefferies
7d ago
OPT
Premium
The Fly
Opthea downgraded to Neutral from Buy at H.C. Wainwright
7d ago
OPT
Premium
The Fly
CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls
7d ago
AJG
AON
Premium
Ratings
Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
7d ago
OPT
Premium
Ratings
Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
8d ago
OPT
Premium
Company Announcements
Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns
8d ago
6K
OPT
Premium
The Fly
Opthea COAST trial misses primary endpoint, enters talks with DFA Investors
8d ago
OPT
Premium
The Fly
Opthea Ltd (ADR) trading halted, news pending
15d ago
OPT
Premium
Ratings
Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
29d ago
OPT
Premium
The Fly
Opthea announces Phase 2b Wet AMD publication
29d ago
OPT
Premium
Company Announcements
Opthea Limited Reports Increased Losses Amid Clinical Advancements
30d ago
OPT
Premium
The Fly
Opthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last year
1M ago
OPT
Premium
The Fly
Opthea announces anticipated milestones
1M ago
OPT
Premium
Ratings
Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment
1M ago
OPT
Premium
The Fly
Opthea completes drug product PPQ campaign
1M ago
OPT
Premium
Ratings
Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position
1M ago
OPT
Premium
The Fly
Opthea completes COAST final week 52 patient visit
1M ago
OPT
Premium
Company Announcements
Opthea Completes Key Phase 3 Trial Milestone in Wet AMD Treatment
1M ago
6K
OPT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.